berberine has been researched along with Acute Hepatic Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, Q; Li, R; Wang, Y; Wu, X; Xu, L; Ye, J; Zhang, M; Zhang, Y; Zhao, W; Zheng, X | 1 |
| Chai, FN; Li, XG; Li, YF; Ma, WY; Xiang, HM; Xu, HS; Ye, XL; Zhang, J | 1 |
2 other study(ies) available for berberine and Acute Hepatic Failure
| Article | Year |
|---|---|
Berberine protects acute liver failure in mice through inhibiting inflammation and mitochondria-dependent apoptosis.
Topics: Animals; Apoptosis; Berberine; Cytoprotection; Galactosamine; Inflammation; Liver Failure, Acute; Male; Mice; Mice, Inbred ICR; Mitochondria; NF-kappa B; RAW 264.7 Cells; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2018 |
Protective effect of Coptisine from Rhizoma Coptidis on LPS/D-GalN-induced acute liver failure in mice through up-regulating expression of miR-122.
Topics: Animals; Berberine; Coptis chinensis; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Galactosamine; Gene Expression; Hep G2 Cells; Humans; Lipopolysaccharides; Liver Failure, Acute; Mice; MicroRNAs; Protective Agents; Random Allocation; Treatment Outcome; Up-Regulation | 2018 |